MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Townsend, A. J.
Right arrow Articles by Cheng, Y. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Townsend, A. J.
Right arrow Articles by Cheng, Y. C.

Sequence-specific effects of ara-5-aza-CTP and ara-CTP on DNA synthesis by purified human DNA polymerases in vitro: visualization of chain elongation on a defined template

AJ Townsend and YC Cheng

Pharmacology Department, University of North Carolina, Chapel Hill 27514.

1-beta-D-arabinofuranosyl-5-aza-cytosine (ara-5-aza-Cyd) is an analog of 1-beta-D-arabinofuranosylcytosine (ara-C), which resembles ara-C in anabolic metabolism, incorporation into DNA, and inhibition of DNA replication. Human T-lymphoblastic cells (Molt-4) incorporate three- to fivefold more ara-5-aza-Cyd than ara-C into DNA during 5-8 hr exposure. Although ara-5-aza-Cyd and its triphosphate metabolite are unstable in aqueous solution, the aza-analog was much more stable in solution when incorporated into native DNA isolated from Molt-4 cells. By using gapped duplex DNA as a substrate for purified human DNA polymerases alpha and beta, inhibition of [3H]-dCTP incorporation by ara-5-aza-CTP and ara-CTP was competitive, with Ki values for alpha of 11 and 1.5 microM, respectively. Ki values for polymerase beta were 39 and 7.6 microM, respectively. A DNA elongation assay was adapted from DNA sequencing technology, using singly primed bacteriophage M13mp19 or M13mp9 (+)-DNA. Elongation of 5'-[32P]-labeled primer by polymerase alpha is slowed considerably by incorporation of one ara-CMP and to a lesser extent after incorporation of one ara-5-aza-CMP. Neither analog significantly affected elongation by polymerase beta after a single incorporation. However, neither polymerase alone could appreciably extend the growing chain if two consecutive ara-5-aza-CMP or ara-CMP analogs were incorporated. Thus, if similar mechanisms are operant in intact cells, the greater incorporation of ara-5-aza-Cyd than ara-C into DNA may be due to a more facile elongation of the nascent DNA strand by polymerase alpha after incorporation of a single analog. The effect in vitro of incorporation of either analog on DNA chain elongation is widely variable, depending on the identity of the polymerase involved and the sequence of the DNA template being copied.

Volume 32, Issue 3, pp. 330-339, 09/01/1987
Copyright © 1987 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Cancer Res.Home page
Y. Wang, X. Liu, A. Matsuda, and W. Plunkett
Repair of 2'-C-Cyano-2'-Deoxy-1-{beta}-D-arabino-Pentofuranosylcytosine-Induced DNA Single-Strand Breaks by Transcription-Coupled Nucleotide Excision Repair
Cancer Res., May 15, 2008; 68(10): 3881 - 3889.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Qin, E. M. Youssef, J. Jelinek, R. Chen, A. S. Yang, G. Garcia-Manero, and J.-P. J. Issa
Effect of Cytarabine and Decitabine in Combination in Human Leukemic Cell Lines
Clin. Cancer Res., July 15, 2007; 13(14): 4225 - 4232.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. M. Roy, K. N. Tiwari, W. B. Parker, J. A. Secrist III, R. Li, and Z. Qu
Antiangiogenic activity of 4'-thio-{beta}-D-arabinofuranosylcytosine.
Mol. Cancer Ther., September 1, 2006; 5(9): 2218 - 2224.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Zhao and H. Piwnica-Worms
ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1
Mol. Cell. Biol., July 1, 2001; 21(13): 4129 - 4139.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Azuma, P. Huang, A. Matsuda, and W. Plunkett
2'-C-Cyano-2'-deoxy-1-{beta}-D-arabino-pentofuranosylcytosine: A Novel Anticancer Nucleoside Analog that Causes Both DNA Strand Breaks and G2 Arrest
Mol. Pharmacol., April 1, 2001; 59(4): 725 - 731.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. D. Cline and N. Osheroff
Cytosine Arabinoside Lesions Are Position-specific Topoisomerase II Poisons and Stimulate DNA Cleavage Mediated by the Human Type II Enzymes
J. Biol. Chem., October 15, 1999; 274(42): 29740 - 29743.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z.-M. Yuan, Y. Huang, M.-M. Fan, C. Sawyers, S. Kharbanda, and D. Kufe
Genotoxic Drugs Induce Interaction of the c-Abl Tyrosine Kinase and the Tumor Suppressor Protein p53
J. Biol. Chem., October 25, 1996; 271(43): 26457 - 26460.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Harrington and F. W. Perrino
The Effects of Cytosine Arabinoside on RNA-primed DNA Synthesis by DNA Polymerase alpha-Primase
J. Biol. Chem., November 3, 1995; 270(44): 26664 - 26669.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1987 by the American Society for Pharmacology and Experimental Therapeutics